Consillium
Investment Details
Investor Type
Family Office
Asset Class Focus
Private Equity, Real Estate, Venture Capital
Stage Focus
Growth, Late Stage, Pre-IPO, Buyout
Geographical Focus
United States, Canada, Japan, Australia, Singapore, China, India, Brazil, Mexico, Indonesia, South Korea, Malaysia, New Zealand, Thailand, European Union, Chile, Argentina, Colombia, Peru, Czech Republic
Industries Focus
- Technology
- Healthcare
- Consumer Goods
- Retail
- Agriculture
- Construction
- Medical Devices
- Diagnostics
- Manufacturing
- Biotechnology
- New Materials
- Energy Storage
- Sports Equipment
- Additive Manufacturing
- Applied Biotech
Investment Size:
20,000,000 to 50,000,000 USD
Investor Details Founded: 2016
Consillium is a family office established by entrepreneur Tomáš Němec, dedicated to preserving and growing family wealth through private wealth management and investments with compelling value creation and growth potential. The firm acts as an active equity partner and entrepreneurial investor, supporting great ideas to thrive and management to excel. Consillium focuses on long-term performance, operational improvements, and potential for international expansion.
The firm's investment strategy emphasizes sectors such as manufacturing, particularly in the production, service, and distribution of machines and components for agriculture, industry, and construction, as well as sports equipment, including design, manufacture, and trade. Additionally, Consillium invests in early-stage businesses with global potential in applied biotechnology, new materials, energy storage, and additive manufacturing. The firm operates in the European Union and North America, with a preferred equity value range of €20-50 million.
Consillium's portfolio includes businesses in the ski manufacturing industry under the Kästle brand, in the biotechnology industry under the BioVendor brand, and in business process services under the OKIN brand. The firm is committed to supporting management teams and fostering growth through active involvement and strategic guidance.
Requirements
- Strong value creation and growth potential
- Operational improvements
- Potential for international expansion
- Preferred equity value range of €20-50 million
Contact
[Official Website Hidden]
[HQ Location Hidden]
[Email Hidden]
[Contact Number Hidden]
Portfolio Companies
- Kästle
- BioVendor
- OKIN
Mentioned In
-
$9.95
-
$49.95
-
$29.95
-
$19.95
-
$9.95
-
$19.95
-
$24.95
-
$99.00
Claim this Investor
Are you an official representative of Consillium?
Claim this investor to update information, manage your profile, and get a verified seal.
Claim